- Home
- SNY vs BUD Comparison
SNY vs BUD Comparison
Compare SNY & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- BUD
- Stock Information
- Founded
- SNY 1994
- BUD 1366
- Country
- SNY France
- BUD Belgium
- Employees
- SNY N/A
- BUD N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- BUD Beverages (Production/Distribution)
- Sector
- SNY Health Care
- BUD Consumer Staples
- Exchange
- SNY Nasdaq
- BUD Nasdaq
- Market Cap
- SNY 116.1B
- BUD 124.6B
- IPO Year
- SNY N/A
- BUD N/A
- Fundamental
- Price
- SNY $52.02
- BUD $62.44
- Analyst Decision
- SNY Buy
- BUD Buy
- Analyst Count
- SNY 4
- BUD 2
- Target Price
- SNY $61.50
- BUD $71.50
- AVG Volume (30 Days)
- SNY 2.3M
- BUD 2.3M
- Earning Date
- SNY 10-24-2025
- BUD 10-30-2025
- Dividend Yield
- SNY 3.07%
- BUD 1.52%
- EPS Growth
- SNY 105.93
- BUD N/A
- EPS
- SNY 8.67
- BUD 3.12
- Revenue
- SNY $53,890,648,839.00
- BUD $58,605,000,000.00
- Revenue This Year
- SNY $2.37
- BUD $0.83
- Revenue Next Year
- SNY $6.51
- BUD $5.36
- P/E Ratio
- SNY $11.84
- BUD $20.36
- Revenue Growth
- SNY N/A
- BUD N/A
- 52 Week Low
- SNY $44.62
- BUD $45.94
- 52 Week High
- SNY $60.12
- BUD $72.13
- Technical
- Relative Strength Index (RSI)
- SNY 63.33
- BUD 53.13
- Support Level
- SNY $48.55
- BUD $62.63
- Resistance Level
- SNY $52.68
- BUD $65.22
- Average True Range (ATR)
- SNY 0.68
- BUD 0.91
- MACD
- SNY 0.15
- BUD 0.10
- Stochastic Oscillator
- SNY 85.01
- BUD 55.20
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.